• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Etching of glass microchips with supercritical water?
  Pavel Karásek,Jakub Grym,Michal Roth,Josef Planeta,Franti?ek Foret Lab Chip, 2015,15, 311-318
• 3. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Organooxygen compounds
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds

Professional Introduction to O-(3-methylbutyl)hydroxylamine hydrochloride (CAS No. 51951-35-0)

O-(3-methylbutyl)hydroxylamine hydrochloride is a significant compound in the field of chemical and pharmaceutical research, characterized by its unique structural and functional properties. This compound, identified by the CAS number 51951-35-0, has garnered considerable attention due to its potential applications in various biochemical and medicinal processes. The introduction aims to provide a comprehensive overview of this compound, highlighting its chemical structure, synthesis methods, and recent advancements in its application within the pharmaceutical industry.

The chemical structure of O-(3-methylbutyl)hydroxylamine hydrochloride consists of a hydroxylamine moiety attached to a 3-methylbutyl group, with the hydrochloride salt form enhancing its solubility in aqueous solutions. This structural configuration imparts unique reactivity and stability, making it a valuable intermediate in organic synthesis and drug development. The compound’s ability to participate in nucleophilic substitutions and redox reactions underscores its versatility in chemical transformations.

In terms of synthesis, O-(3-methylbutyl)hydroxylamine hydrochloride can be prepared through several methodologies, including the reaction of 3-methylbutanol with nitrous acid followed by reduction, or via the nucleophilic substitution of 3-methylbutyl halides with hydroxylamine salts. Recent studies have explored catalytic processes that improve yield and purity, reducing the environmental impact of its production. These advancements align with the growing emphasis on sustainable chemistry practices in industrial applications.

The pharmaceutical relevance of O-(3-methylbutyl)hydroxylamine hydrochloride is evident from its role as a precursor in the synthesis of various active pharmaceutical ingredients (APIs). Its structural features make it a suitable candidate for developing drugs targeting neurological disorders, cardiovascular diseases, and inflammatory conditions. For instance, derivatives of this compound have been investigated for their potential in modulating enzyme activities involved in metabolic pathways relevant to these diseases.

Recent research has highlighted the compound’s utility in the development of novel antiviral agents. The hydroxylamine group’s ability to interact with viral proteases and polymerases has been exploited to design inhibitors that disrupt viral replication cycles. Studies published in leading journals have demonstrated promising results in vitro, suggesting that O-(3-methylbutyl)hydroxylamine hydrochloride-based compounds could offer new therapeutic strategies against emerging infectious diseases.

The compound’s pharmacokinetic properties have also been a focus of investigation. Its solubility profile and stability under physiological conditions make it an attractive candidate for formulation into oral and injectable medications. Advanced computational models have been employed to predict how O-(3-methylbutyl)hydroxylamine hydrochloride behaves within biological systems, aiding in the design of more effective drug delivery systems.

In conclusion, O-(3-methylbutyl)hydroxylamine hydrochloride (CAS No. 51951-35-0) represents a promising compound with diverse applications in pharmaceutical research and development. Its unique chemical properties, coupled with recent advancements in synthetic methodologies and drug design, position it as a key player in addressing various health challenges. As research continues to uncover new possibilities, this compound is poised to contribute significantly to the advancement of medicinal chemistry and therapeutic innovation.

• 4490-82-8(O-Butylhydroxylamine hydrochloride)
• 75852-80-1(O-(cyclobutylmethyl)hydroxylamine hydrochloride)
• 854382-69-7(O-(Cyclopentylmethyl)hydroxylamine hydrochloride)
• 854382-74-4(O-(2-cyclopropylethyl)hydroxylamine hydrochloride)
• 83670-47-7(O-(2-ethylhexyl)hydroxylamine)
• 19411-65-5(O-(3-Methyl-butyl)-hydroxylamine hydrochloride)
• 1508058-73-8(O-(3,3-dimethylbutyl)hydroxylamine)
• 1373211-33-6(O-(2-methylbutyl)hydroxylamine)
• 74124-04-2(O-(cyclopropylmethyl)hydroxylamine;hydrochloride)
• 34955-09-4(O-(Cyclohexylmethyl)hydroxylamine Hydrochloride)